货号:A586998
同义名:
ED-71; 2-(3-hydroxypropoxy)-1,25-dihydroxyvitamin D3
Eldecalcitol 是一种维生素 D 类似物,用于骨质疏松相关机制研究。
HazMat Fee + There will be a HazMat fee per item when shipping a dangerous goods. The HazMat fee will be charged to your UPS/DHL/FedEx collect account or added to the invoice unless the package is shipped via Ground service. Ship by air in Excepted Quantity (each bottle), which is up to 1g/1mL for class 6.1 packing group I or II, and up to 25g/25ml for all other HazMat items.
| Type | HazMat fee for 500 gram (Estimated) |
| Excepted Quantity | USD 0.00 |
| Limited Quantity | USD 15-60 |
| Inaccessible (Haz class 6.1), Domestic | USD 80+ |
| Inaccessible (Haz class 6.1), International | USD 150+ |
| Accessible (Haz class 3, 4, 5 or 8), Domestic | USD 100+ |
| Accessible (Haz class 3, 4, 5 or 8), International | USD 200+ |


| 规格 | 价格 | 会员价 | 库存 | 数量 | |||
|---|---|---|---|---|---|---|---|
| {[ item.pr_size ]} |
{[ getRatePriceInt(item.pr_rmb, 1,1) ]} {[ getRatePriceInt(item.pr_rmb_sale, 1,1) ]} {[ suihuo_tips(item.pr_tag_price, item.pr_am) ]} |
{[ getRatePriceInt(item.pr_rmb, 1,1) ]} {[ getRatePriceInt(item.pr_rmb,item.pr_rate,1) ]} {[ suihuo_tips(item.pr_tag_price, item.pr_am) ]} |
{[ getRatePriceInt(item.pr_rmb, 1,1) ]}{[ suihuo_tips(item.pr_tag_price, item.pr_am) ]} | {[ getRatePrice(item.pr_rmb_sale, 1,1,item.mem_isinteger) ]} {[ getRatePrice(item.pr_rmb,item.pr_rate,item.mem_rate,item.mem_isinteger) ]} {[ getRatePrice(item.pr_rmb,1,item.mem_rate,item.mem_isinteger) ]} | 现货 | 1周 咨询 | - + |
快速发货 顺丰冷链运输,1-2 天到达
品质保证
技术支持
免费溶解

| 描述 | Eldecalcitol, an analog of vitamin D, is a drug used for the treatment of osteoporosis. |
| Concentration | Treated Time | Description | References | |
| CX3CR1-positive cells from CX3CR1-EGFP knockin mice | 10^-9 to 10^-8 M | 2 days | Suppressed S1PR2 expression | Proc Natl Acad Sci U S A. 2013 Apr 23;110(17):7009-13 |
| CSF1R-positive cells from CSF1R-EGFP transgenic mice | 10^-9 to 10^-8 M | 2 days | Suppressed S1PR2 expression | Proc Natl Acad Sci U S A. 2013 Apr 23;110(17):7009-13 |
| RAW264.7 cells | 10^-9 to 10^-8 M | 2 days | Suppressed S1PR2 expression and enhanced chemotaxis to S1P | Proc Natl Acad Sci U S A. 2013 Apr 23;110(17):7009-13 |
| RAW264.7 cells | 1 × 10–9 M | 48 hours | To evaluate the effect of ED-71 on RAW264.7 cell polarization, results showed that ED-71 alone promoted M2 macrophage polarization. | Stem Cell Res Ther. 2022 Mar 21;13(1):113 |
| CD4+ T cells | 1 nM | 48 hours | To evaluate the effect of ED-71 on Treg cell differentiation under high glucose conditions, results showed ED-71 improved HG-inhibited Treg cell differentiation. | Cell Mol Life Sci. 2024 Oct 5;81(1):423 |
| Human gingival fibroblasts (HGFs) | 0, 0.5, 5, 50 nM | 24 hours | To evaluate the inhibitory effect of ED-71 on LPS-induced cell death. Results showed that ED-71 pretreatment significantly reduced LPS-induced cell death. | Drug Des Devel Ther. 2020 Nov 13;14:4901-4913 |
| C2C12 cells | 0.1, 1, and 10 nM | 24 hours | To investigate the effect of eldecalcitol on TNF-α-induced muscle atrophy. Eldecalcitol significantly inhibited the expression of MuRF-1 and Atrogin-1, increased the diameter of myotubes, and inhibited the NF-κB signaling pathway. | Skelet Muscle. 2023 Dec 19;13(1):22 |
| Administration | Dosage | Frequency | Description | References | ||
| C57BL/6J male mice | Tail suspension model | Intraperitoneal injection | 3.5 or 5 ng | Twice a week for 3 weeks | To investigate the effect of eldecalcitol on tail suspension-induced muscle atrophy and osteoporosis. Eldecalcitol significantly improved grip strength, restored muscle weight, improved bone microarchitecture, and restored the impaired oxidative defense system. | Skelet Muscle. 2023 Dec 19;13(1):22 |
| C57BLKS/J Iar-+ Leprdb/+ Leprdb mice | Diabetic osteoporosis model | Oral | 0.25 μg/kg | 3 times per week for 4 weeks | To evaluate the effect of ED-71 on bone formation in diabetic osteoporosis mice, results showed that ED-71 significantly enhanced bone formation and promoted M2 macrophage polarization. | Stem Cell Res Ther. 2022 Mar 21;13(1):113 |
| Mice | Glucocorticoid-induced osteoporosis model | Oral gavage | 50 ng/kg/d | 5 times per week for 8 weeks | Prevented GC-induced upregulation of atrogin1 and MuRF1 expression, preserved bone structure and function | JCI Insight. 2024 Nov 8;9(21):e182664 |
| Mice | Type 2 diabetes model | Oral | 0.25 µg/kg | 3 times per week for 4 weeks | To evaluate the therapeutic effects of ED-71 on diabetic osteoporosis and glucolipid metabolic disorder, results showed ED-71 attenuated bone loss and marrow adiposity while improving glucolipid metabolism. | Cell Mol Life Sci. 2024 Oct 5;81(1):423 |
| Mice | Ovariectomy-induced osteoporosis model | Oral | 50 ng/kg body weight | Once daily for 4 weeks | Prevented osteoporosis and suppressed S1PR2 expression in circulating monocytes | Proc Natl Acad Sci U S A. 2013 Apr 23;110(17):7009-13 |
| Rats | Ovariectomized rat model | Oral | 30 or 90 ng/kg body weight | Five times per week for 12 weeks | To examine the effects of Eldecalcitol on bone in ovariectomized rats, showing that ELD increased bone volume and trabecular thickness, reduced osteoclast numbers, and preferentially induced minimodeling-based bone formation in the epiphyses. | Int J Mol Sci. 2024 Apr 11;25(8):4257 |
| 计算器 | ||||
| 存储液制备 | ![]() |
1mg | 5mg | 10mg |
|
1 mM 5 mM 10 mM |
2.04mL 0.41mL 0.20mL |
10.19mL 2.04mL 1.02mL |
20.38mL 4.08mL 2.04mL |
|
| CAS号 | 104121-92-8 |
| 分子式 | C30H50O5 |
| 分子量 | 490.72 |
| SMILES Code | O[C@H]1[C@@H](OCCCO)[C@H](O)C(/C(C1)=C\C=C2[C@]3([H])CC[C@H]([C@H](C)CCCC(C)(O)C)[C@@]3(C)CCC\2)=C |
| MDL No. | MFCD25977156 |
| 别名 | ED-71; 2-(3-hydroxypropoxy)-1,25-dihydroxyvitamin D3; Edirol; 2-(3-Hydroxypropoxy)calcitriol; 1,25-dihydroxyvitamin D3 |
| 运输 | 蓝冰 |
| 存储条件 |
In solvent -20°C: 3-6个月 -80°C: 12个月 Pure form Sealed in dry, store in freezer, under -20°C |
| 溶解方案 |
DMSO: 3 mg/mL(6.11 mM),配合低频超声,并水浴加热至45℃助溶,注意:DMSO长时间开封后,会吸水并导致溶解能力下降,请避免使用长期开封的DMSO |
沪公网安备 31011702889066号
沪ICP备2024050318号-1